| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 23, 2025 | Moleculin Biotech, Inc. | CFO | Buy | 95.0 | +268,555 | 532.93% | ✗ | $99.5K |
| Jun 16, 2025 | Jun 18, 2025 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -203 | -1.66% | ✗ | $139.1 |
| Jun 22, 2024 | Jun 25, 2024 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -1,053 | -8.48% | ✗ | $3.9K |
| Jun 20, 2024 | Jun 21, 2024 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -636 | -7.29% | ✗ | $2.4K |
| Jun 16, 2024 | Jun 18, 2024 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -196 | -3.16% | ✗ | $811.4 |
| Dec 26, 2023 | Dec 27, 2023 | Moleculin Biotech, Inc. | CFO | Buy | 91.3 | +28,986 | 56.21% | ✗ | $20K |
| Jun 20, 2023 | Jun 22, 2023 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -9,676 | -15.80% | ✗ | $5.5K |
| Jun 16, 2023 | Jun 20, 2023 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -3,044 | -12.89% | ✗ | $1.7K |
| Jun 16, 2022 | Jun 21, 2022 | Moleculin Biotech, Inc. | CFO | Sell | 27.5 | -3,044 | -21.49% | ✗ | $4K |
| Apr 25, 2017 | Apr 26, 2017 | Moleculin Biotech, Inc. | CFO | Buy | 90.0 | +10,000 | 100.00% | ✗ | $8.6K |
| Aug 18, 2015 | Aug 18, 2015 | InfuSystem Holdings, Inc | CFO | Buy | 82.5 | +1,000 | 3.57% | ✗ | $2.9K |
| Jun 15, 2015 | Jun 17, 2015 | InfuSystem Holdings, Inc | CFO | Buy | 77.5 | +312 | 1.13% | ✗ | $973.4 |
| May 15, 2015 | May 18, 2015 | InfuSystem Holdings, Inc | CFO | Buy | 91.3 | +4,270 | 23.29% | ✗ | $13.1K |
| Mar 13, 2014 | Mar 14, 2014 | InfuSystem Holdings, Inc | CFO | Buy | 91.3 | +5,000 | 100.00% | ✗ | $13.9K |